NCT05989932View on ClinicalTrials.gov

Real-world Experience on the Use of Upadacitinib in the Treatment of Moderate-severe Adult Atopic Dermatitis (ERUDA)

CompletedOBSERVATIONAL

Enrollment

146

Participants

Timeline

Start Date

December 15, 2021

Primary Completion Date

April 19, 2024

Study Completion Date

April 19, 2024

Conditions

Atopic Dermatitis

Interventions

OTHER

Upadacitinib

Real-world on the use of Upadacitinib

Trial Locations (1)

00168

Irccs Fondazione Policlinico Gemelli, Roma

All Listed Sponsors

lead

Societa Italiana di Dermatologia Medica, Chirurgica, Estetica e di Malattie Sessualmente Trasmesse

OTHER

NCT05989932 - Real-world Experience on the Use of Upadacitinib in the Treatment of Moderate-severe Adult Atopic Dermatitis (ERUDA) | Biotech Hunter | Biotech Hunter